000 01257 a2200361 4500
005 20250518021632.0
264 0 _c20190617
008 201906s 0 0 eng d
022 _a0040-3660
024 7 _a10.26442/terarkh201890659-64
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVikulova, O K
245 0 0 _aRenal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus.
_h[electronic resource]
260 _bTerapevticheskii arkhiv
_cJun 2018
300 _a59-64 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlbuminuria
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aGlucagon-Like Peptide 1
650 0 4 _aGlucagon-Like Peptide Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
650 0 4 _aKidney
_xdrug effects
700 1 _aZuraeva, Z T
700 1 _aMikhaleva, O V
700 1 _aNikankina, L V
700 1 _aShamkhalova, M Sh
700 1 _aShestakova, M V
700 1 _aDedov, I I
773 0 _tTerapevticheskii arkhiv
_gvol. 90
_gno. 6
_gp. 59-64
856 4 0 _uhttps://doi.org/10.26442/terarkh201890659-64
_zAvailable from publisher's website
999 _c29311797
_d29311797